The 16-Year Experience in Treating Low-Risk Gestational Trophoblastic Neoplasia Patients With Failed Primary Methotrexate Chemotherapy

Journal of Gynecologic Oncology - South Korea
doi 10.3802/jgo.2020.31.e36
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy (KAMJE)

Related search

First Line Chemotherapy in Low Risk Gestational Trophoblastic Neoplasia

2008English

A Case of Methotrexate Resistant Gestational Trophoblastic Neoplasia

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
2018English

Efficacy and Risk Factors Associated to Resistance to Single-Agent Chemotherapy in Low-Risk Gestational Trophoblastic Neoplasia

Open Journal of Obstetrics and Gynecology
2016English

OP20.01: An Independent Predictor for Methotrexate Resistance in Low-Risk Gestational Trophoblastic Neoplasia With Myometrial Invasion: A Prospective Study

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2017English

The Value of an Initial Drop in Human Chorionic Gonadotropin Levels in Predicting a Response to Methotrexate in Women With Low-Risk Gestational Trophoblastic Neoplasia

Ginekologia Polska
GynecologyObstetrics
2019English

Pulmonary Metastases Increase Chemotherapy Resistance and Recurrence of Gestational Trophoblastic Neoplasia

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2020English

A Rare Cause for Gestational Trophoblastic Neoplasia: Placental Site Trophoblastic Tumor

Open Journal of Obstetrics and Gynecology
2013English

Distinct Gestational Trophoblastic Neoplasia - Different Entities, Specific Management

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
2017English

Pembrolizumab Is Effective for Drug-Resistant Gestational Trophoblastic Neoplasia

The Lancet
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy